Global Healthcare Analytical Testing Services Market to Grow at a CAGR of 10% During the Forecast Period (2025–2030): Wissen Research

Global healthcare analytical testing services market was valued at USD 11.2 billion in 2024 and is projected to reach USD 19.8 billion by 2030, expected to grow at a CAGR of 10% during the forecast period, 2025-2030.

Sheridan, Sept. 30, 2025 (GLOBE NEWSWIRE) -- According to the latest market report published by Wissen Research, the global healthcare analytical testing services market was valued at USD 11.2 billion in 2024. Furthermore, the market is expected to grow at a CAGR of 10% during the forecast period from 2025 to 2030.

Healthcare analytical testing services market report pricing @ https://www.wissenresearch.com/Pricing/

Healthcare Analytical Testing Services Market Summary

US Healthcare Analytical Testing Service Market Size

Furthermore, the US with USD 4.2 billion market in 2024, held a largest share in the global healthcare analytical testing service market and is likely to show the growth at a CAGR of 10.1% within this market, during the forecast period (2025-2030)

Growth Drivers

• Increasing regulatory mandates requiring comprehensive data for drug approvals and market surveillance.
• Growing emphasis on personalized medicine driving demand for sophisticated biomarker analysis.
• The rising prevalence of chronic and complex diseases necessitates advanced diagnostic insights.
• Adoption of digital health technologies generating vast datasets requiring robust analytical processing.
  

Opportunities

• Expansion into emerging markets with improving healthcare infrastructure and increasing disease burden.
• Leveraging AI and machine learning to offer predictive analytics and enhanced data interpretation services.
• Developing specialized testing services for novel therapeutic areas like gene and cell therapies.
• Forming strategic partnerships with pharma/biotech companies for integrated R&D and clinical trial support.

Key Insights from Healthcare Analytical Testing Service Market Analysis

Bioanalytical Testing dominated the healthcare analytical testing services market by testing type in 2024. 

In 2024, Bioanalytical Testing was the largest segment in the healthcare analytical testing market because it forms the critical foundation for evaluating the safety and efficacy of new pharmaceutical products throughout their development lifecycle. This segment encompasses the essential quantification of drugs and their metabolites in biological matrices (like blood, plasma, urine) in preclinical and clinical studies, generating the quantitative data required for pharmacokinetic, pharmacodynamic, and toxicokinetic assessments. Given the high volume and regulatory stringency (e.g., FDA 21 CFR Part 58, EMA guidelines) associated with bioequivalence studies for generic drugs, clinical pharmacology trials for new chemical entities, and biomarker analysis, the demand for validated, compliant bioanalytical services remains consistently high and voluminous, making it the dominant component of the market.

Pharmaceutical Companies held the largest market share in 2024 in the healthcare analytical testing services market by End User. 

Pharmaceutical Companies were the largest end-users of healthcare analytical testing services in 2024. This is due to their heavy reliance on extensive testing throughout the drug development process – from preclinical studies and clinical trial sample analysis (like pharmacokinetics) to quality control and regulatory compliance. The constant flow of new, complex drug candidates necessitates specialized analytical services. Although Hospitals & Clinics perform high volumes of diagnostics, the depth and critical nature of testing required by Pharma and Biopharma for bringing therapies to market solidify their dominant position. Other industries like Medical Devices and Cosmetics also use these services, but less extensively. 

North America is projected to hold the largest market share in the healthcare analytical testing services market during the forecast period (2025-2030).

North America commanded the highest market share in the healthcare analytical testing services industry during the forecast period (2025-2030), driven by the presence of a highly developed pharmaceutical and biotechnology sector with extensive R&D activities, robust healthcare infrastructure, and significant investments in advanced diagnostic technologies. For instance, the United States remains a global leader in drug development, necessitating vast amounts of bioanalytical and genomic testing. Furthermore, strong regulatory frameworks (like FDA guidelines), high healthcare expenditure, and early adoption of precision medicine and next-generation sequencing technologies across both clinical and research settings in the U.S. and Canada fueled market dominance. The region also hosts numerous leading diagnostic laboratories and testing companies.

Request Customized Report @ https://www.wissenresearch.com/ask-for-customization/

Contact us for free sample of healthcare analytical testing service market report: https://www.wissenresearch.com/contact-us/

Other Latest Reports from Wissen Research

• Immunoassay Market
• Lateral Flow Assays Market
• Molecular Assay Market
• CAR T Cell Therapy Market
• Diagnostic Imaging Market
• Wearable Technology Market
• In-Vitro Diagnostics Market
• Digital Diabetes Management Market
• Veterinary Practice Management Software Market
• HIV Diagnostics Market
• Angiography Equipment Market
• Atrial Fibrillation Market
• Diagnostics ECG Market
• Respiratory Diagnostics Market

About us

Wissen Research is a leading market research firm that serves over 800 clients, with 40% of the top 2,000 companies relying on us for insights into key business questions and the identification of new high-growth and niche revenue opportunities. We offer exclusive market intelligence from over 120 subject matter experts and analysts, complemented by our high-growth niche market studies and consulting services.

Our research methodology delivers quantifiable and actionable insights into interconnected market ecosystems shaped by disruptive technologies and emerging markets. We not only focus on factors that will impact our clients' revenue but also explore what could affect their customers' revenue by revealing latent and adjacent market opportunities.

We collaborate across all B2B sectors, engaging with C-level executives in areas such as R&D, intellectual property, strategy, marketing, sales, product development, and M&A.

Mayur Jain
Wissen Research LLC
Gould St, Ste R
Sheridan, WY 82801
Phone: (+91) 7814300364
info@wissenresearch.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.